Total Funding
91
72
Total FundingGrant raised
Growth Score 91 in past quarter
-3 pts
Heat Score 72 in past quarter
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
56449
Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services.
- Sayjune Kim: President and Chief Executive Officer
About the Company
Surginex is a biological drug development company intended to develop next-generation bio platforms and new drugs. Surginex develops drugs with capabilities ranging from artificial intelligence-based new drug platforms to molecular biology experiments.